Bone marrow aspirate and bone allograft to treat acetabular bone defects in revision total hip arthroplasty: Preliminary report

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 16, 2013, Pages 2240-2249

  Vulcano, E ^a   Murena, L ^a   Falvo, D A ^a   Baj, A ^a   Toniolo, A ^a   Cherubino, P ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Bone defects; Bone marrow; Bone marrow concentrate; Mesenchymal stem cells; Revision THA; THA

Indexed keywords

TISSUE SCAFFOLD;

ACETABULUM; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE ALLOGRAFT; BONE DEFECT; BONE MARROW BIOPSY; CELL ADHESION; CELL NUCLEUS; CLINICAL ARTICLE; CYTOPATHOGENIC EFFECT; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HIP RADIOGRAPHY; HUMAN; HUMAN CELL; ILIAC CREST; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MICROBIAL CONTAMINATION; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PROSTHESIS LOOSENING; REOPERATION; SEROLOGY; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; VIRUS GENOME; VIRUS REACTIVATION; VIRUS REPLICATION; WOUND HEALING;

ACETABULUM; AGED; ARTHROPLASTY, REPLACEMENT, HIP; BONE MARROW CELLS; BONE TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; REOPERATION; TIME FACTORS; TISSUE SCAFFOLDS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84884241603     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. KURTZ S, MOWAT F, ONG K, CHAN N, LAU E, HALPERN M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87: 1487-197
2. NATIONAL JOINT REGISTRY. National Joint Registry for England and Wales. 2nd Annual Report 2005
3. MALCHAU H, HERBERTS P, EISLER T, GARELLICK G, SODERMAN P. The Swedish Total Hip Replacement Register. J Bone Joint Surg Am 2002; 84(Suppl 2) 2-20.
4. Erratum in: J Bone Joint Surg Am 2004; 86: 363
5. CANADIAN INSTITUTE FOR HEALTH INFORMATION, Canadian Joint Replacement Registry (CJRR). 2004 report: total hip and total knee replacements in Canada. 2004
6. AUSTRALIAN ORTHOPAEDIC ASSOCIATION. National Joint Replacement Registry annual report 2005. 2005
7. GIE GA, LINDER L, LING R, SIMON J-P, SLOOF TJ, TIMPERLEY A. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg (Br) 1993; 75: 14-21
8. SLOOFF TJ, BUMA P, SCHREURS BW, SCHIMMEL JW, HUISKES R, GARDENIERS J. Acetabular and femoral reconstruction with impacted graft and cement. Clin Orthop 1996; 323: 108-115
9. ITOKAZU M, MATSUNAGA T, ISHII M, KUSAKABE H, WYNI Y. Use of arthroscopy and interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Arch Orthop Trauma Surg 1996; 115: 45-48
10. JENSEN S, AABOE M, PINHOLT E, HJORTING-HANSEN E, MELSEN F, RUYTER E. Tissue reaction and material characteristics of four bone substitutes. Int J Oral Maxillofac Implants 1996; 11: 55-66
11. LI SH, LIU Q, DEWIJN JR, ZHOU BL, DEGROOT K. In vitro calcium phosphate formation on a natural composite material, bamboo. Biomaterials 1997; 18: 389-395
12. GALEA G, KOPMAN D, GRAHAM BJM. Supply and demand of bone allograft for revision hip surgery in Scotland. J Bone Joint Surg (Br) 1998; 80: 595-599
13. LUCARELLI E, DONATI D, CENACCHI A, Fornasari PM. Bone reconstruction of large defects using bone marrow derived autologous stem cells. Transfus Apher Sci 2004; 30: 169-174
14. CHARALAMBIDES C, BEER M, COBB AG. Poor results after augmenting autograft with xenograft (Surgibone) in hip revision surgery: a report of 27 cases. Acta Orthop 2005; 76: 544-549
15. TSURUGA E, TAKITA H, ITOH H, WAKISAKA Y, KUBOKI Y. Pore size of porous hydroxyapatite as the cellsubstratum controls BMP-induced osteogenesis. J Biochem 1997; 121: 317-324
16. RANSFORD A, MORLEY T, EDGAR M, WEBB P, PASSUTI N, CHOPIN D, MORIN C, MICHEL F, GARIN C, PRIES D. Synthetic porous ceramic compared with autograft in scoliosis surgery. J Bone Joint Surg (Br) 1998; 80: 13-18
17. GIANNOUDIS PV, EINHORN TA, MARSH D. Fracture healing: the diamond concept. Injury 2007; 38(Suppl 4) S3-6
18. AXELRAD TW, EINHORN TA. Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev 2009; 20: 481-488
19. INTINI G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 2009; 30: 4956-4966
20. GÓMEZ-BARRENA E, ROSSET P, MÜLLER I, GIORDANO R, BUNU C, LAYROLLE P, KONTTINEN YT, LUYTEN FP. Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med 2011; 15: 1266-1286
21. HEMATTI P. Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol 2011; 690: 163-174
22. HWANG NS, ZHANG C, HWANG YS, VARGHESE S. Mesenchymal stem cell differentiation and roles in regenerative medicine. Wiley Interdiscip Rev Syst Biol Med 2009; 1: 97-106
23. ARVIDSON K, ABDALLAH BM, APPLEGATE LA, BALDINI N, CENNI E, GOMEZ-BARRENA E, GRANCHI D, KASSEM M, KONTTINEN YT, MUSTAFA K, PIOLETTI DP, SILLAT T, FINNEWISTRAND A. Bone regeneration and stem cells. J Cell Mol Med 2010; 15: 718-746
24. ITO H. Chemokines in mesenchymal stem cell therapy for bone repair: a novel concept of recruiting mesenchymal stem cells and the possible cell sources. Mod Rheumatol 2011; 21: 113-121
25. BIANCO P, RIMINUCCI M, GRONTHOS S, ROBEY PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192
26. CIAPETTI G, AMBROSIO L, MARLETTA G, BALDINI N, GIUNTI A. Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering. Biomaterials 2006; 27: 6150-6160
27. HERZOG EL, CHAI L, KRAUSE DS. Plasticity of marrowderived stem cells. Blood 2003; 102: 3483-3493
28. KÖRBLING M, KATZ RL, KHANNA A, RUIFROK AC, RONDON G, Albitar M, Champlin RE, Estrov Z. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 2002; 346: 738-746
29. JÄGER M, JELINEK EM, WESS KM, SCHARFSTÄDT A, JACOBSON M, KEVY SV, KRAUSPE R. Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 2009; 4: 34-43
30. OKAZAKI K, MALTEPE E. Oxygen, epigenetics and stem cell fate. Regen Med 2006; 1: 71-83
31. DALLARI D, SAVARINO L, STAGNI C, CENNI E, CENACCHI A, FORNASARI PM, ALBISINNI U, RIMONDI E, BALDINI N, GIUNTI A. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg 2007; 89: 2413-2420
32. United States Pharmacopeia. 2011.USP 34-NF 29
33. CONNOLLY J, GUSE R, LIPPIELLO L, DEHNE R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg 1989; 71: 684-691
34. HERNIGOU P, MATHIEU G, POIGNARD A, MANICOM O, BEAUJEAN F, ROUARD H. Percutaneous autologous bone-marrow grafting for non-unions. Surgical technique. J Bone Joint Surg 2006; 88(Suppl 1) Pt 2: 322-327
35. HERNIGOU P, POIGNARD A, BEAUJEAN F, ROUARD H. Percutaneous autologous bone-marrow grafting for non-unions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg 2005; 87: 1430-1437
36. SONG L, TUAN RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004; 18: 980-982
37. HERMANN PC, HUBER SL, HERRLER T, VON HESLER C, ANDRASSY J, KEVY SV, JACOBSON MS, HEESCHEN C. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant 2008; 16: 1059-1069
38. MOORE MS, MCAULEY JP, YOUNG AM, ENGH CA SR. Radiographic signs of osseointegration in porouscoated acetabular components. Clin Orthop Relat Res 2006; 444: 176-183
39. MAHOMED N, SLEDGE CB, DALTROY L, FOSSEL A, KATZ J. Self-administered satisfaction scale for joint replacement arthroplasty. J Bone Joint Surg (Br) 1997; 80: 9
40. DOMINICI M, LE BLANC K, MUELLER I, SLAPER-CORTENBACH I, MARINI F, KRAUSE D, DEANS R, KEATING A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317
41. BECKER S, MAISSEN O, PONOMAREV I, STOLL T, RAHN B, WILKE I. Osteopromotion by a beta-tricalcium phosphate/bone marrow hybrid implant for use in spine surgery. Spine 2006; 31: 11-17
42. MALARD O, GUICHEUX J, BOULER JM, GAUTHIER O, DE MONTREUIL CB, AGUADO E, PILET P, LEGEROS R, DACULSI G. Calcium phosphate scaffold and bone marrow for bone reconstruction in irradiated area: a dog study. Bone 2005; 36: 323-330
43. HISATOME T, YASUNAGA Y, YANADA S, TABATA Y, IKADA Y, OCHI M. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells.Biomaterials 2005; 26: 4550-4556
44. DALLARI D, FINI M, STAGNI C, ORRICELLI P, NICOLI ALDINI N, GIAVARESI G, CENNI E, BALDINI N, CENACCHI A, BASSI A, GIARDINO R, FORNASARI PM, GIUNTI A. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 2006; 24: 877-888
45. CANCEDDA R, MASTROGIACOMO M, BIANCHI G, DERUBEIS A, MURAGLIA A, QUARTO R. Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp 2003; 249: 133-143
46. JÄGER M, HERTEN M, FOCHTMANN U, FISCHER J, HERNIGOU P, ZILKENS C, HENDRICH C, KRAUSPE R. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011; 29: 173-180
47. BARTHOLOMEW A, STURGEON C, SIATSKAS M, FERRER K, MCINTOSH K, PATIL S, HARDY W, DEVINE S, UCKER D, DEANS R, MOSELEY A, HOFFMAN R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42-48
48. MOOSMANN S, HUTTER J, MOSER C, KROMBACH F, HUSS R. Milieu-adopted in vitro and in vivo differentiation of mesenchymal tissues derived from different adult human CD34-negative progenitor cell clones. Cells Tissues Organs 2005; 179: 91-101
49. PASQUINELLI G, TAZZARI P, RICCI F, VASELLI C, BUZZI M, CONTE R, ORRICO C, FORONI L, STELLA A, ALVIANO F, BAGNARA GP, LUCARELLI E. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct Pathol 2007; 31: 23-31
50. WINER JP, JANMEY PA, MCCORMICK ME, FUNAKI M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A 2009; 15: 147-154
51. MAN D, PLOSKET H, WINLAND-BROWN JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery.Plast Reconstr Surg 2001; 107: 229-237
52. SANCHEZ AR, SHERIDAN PJ, KUPP LI. Is platelet-rich plasma the perfect enhancement factor?: a current review. Int J Oral Maxillofac Implants 2003; 18: 93-103
53. MARX RE, CARLSON ER, EICHSTAEDT RM, SCHIMMELE SR, STRAUSS JE, GEORGEFF KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-646
54. HARRISON P, CRAMER EM. Platelet alpha-granules. Blood Rev 1993; 7: 52-62
55. ANITUA E, ANDIA I, ARDANZA B, NURDEN P, NURDEN AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004; 91: 4-15
56. BUCHOLZ RW, EINHORN TA, MARSH JL. Bone and joint healing. In: Bucholz RW, Heckman JD, Court-Brown C (Eds.) Rockwood & Green?s fractures in adults. Sixth (ed.), Lippincott Williams & Wilkins, 2006; pp. 300-311.
57. MARX RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001; 10: 225-228
58. WHITMAN DH, BERRY RL, GREEN DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55: 1294-1299